INSIGHTS ON DRUG DEVELOPMENT

• Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines

  Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

• Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load

  Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

• Process Intensification: Your Guide To "Doing More With Less"

  Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

• Rapid Automated Selection Of Mammalian Cell Colonies

  Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.

• Fast And Accurate Detection Of Alzheimer's Disease Targets

  9/17/2024

  In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).

• Advancing Infectious Disease Research With This ddPCR System

  3/26/2026

  Efficient digital PCR workflows maximize data from 5µL samples. Achieve high-level multiplexing and faster turnaround times to accelerate discovery and verify NGS findings with total confidence.

• Using DSC And MDSC To Study Material Interactions Of APIs And Excipients

  1/7/2026

  Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.

• High-Throughput IgG Quantification Assay For Cell Line Development

  4/4/2025

  Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.

• Inside Asymchem's Technology-Led Expansion Of Oligonucleotide Capabilities

  4/13/2026

  Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.